Compare

China Pharma Holdings, Inc. vs ProPhase Labs, Inc. vs Camp4 Therapeutics Corp vs Cerenome, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearChina Pharma Holdings, Inc.
CPHI
ProPhase Labs, Inc.
PRPH
Camp4 Therapeutics Corp
CAMP
Cerenome, Inc.
CNSY
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$4.14M$4.34M$3.50M$5.21M
Revenue growth (YoY)-8.5%-35.8%+436.5%-10.5%
Gross margin-3.2%31.9%n/an/a
Operating margin-78.2%-415.4%n/m-293.5%
Net margin-76.9%-339.3%n/m-429.4%
Net income-$3.19M-$14.74M-$80.40M-$22.39M
EPS (Diluted)-$0.74-$1.74-$2.65-$0.29
Operating cash flow$148.3K-$8.34M-$29.55M-$20.77M
Free cash flow$88.9K-$8.34M-$29.83M-$20.84M
Cash & equivalents$345.1K$90.0K$109.52M$4.26M
Total assets$31.00M$59.87M$117.81M$16.32M
Total liabilities$8.26M$56.36M$70.10M$12.33M
Shareholders' equity$22.74M$3.51M$47.70M$4.00M
Return on year-end equity-14.0%-420.3%-168.5%-560.2%
Shares outstanding15.52M8.97M51.90M138.68M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearChina Pharma Holdings, Inc.ProPhase Labs, Inc.Camp4 Therapeutics CorpCerenome, Inc.
Latest$4.14M
Ended 2025-12-31
$4.34M
Ended 2025-12-31
$3.50M
Ended 2025-12-31
$5.21M
Ended 2025-12-31
1 year earlier$4.53M
Ended 2024-12-31
$6.77M
Ended 2024-12-31
$652.0K
Ended 2024-12-31
$5.82M
Ended 2024-12-31
2 years earlier$7.01M
Ended 2023-12-31
$34.98M
Ended 2023-12-31
$350.0K
Ended 2023-12-31
$4.91M
Ended 2023-12-31
3 years earlier$8.10M
Ended 2022-12-31
$122.65M
Ended 2022-12-31
n/an/a
4 years earlier$9.64M
Ended 2021-12-31
$79.04M
Ended 2021-12-31
n/an/a